billHR10093Event Thursday, August 13, 2026Analyzed

Cancer Research Trust Fund Act

Neutral

Summary

The Cancer Research Trust Fund Act (HR10093) was introduced in the House and referred to the Energy and Commerce Committee. It is an early-stage bill with no specified funding amount, and its text is not provided, limiting analysis to procedural status.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR10093 is a procedural early-stage bill with no funding amount or detailed text available.
  • 2.No specific companies or sectors can be confidently linked to this bill at this time.
  • 3.Investors should monitor committee actions and any future amendments for concrete provisions.

Market Implications

Given the bill's early stage and lack of specifics, there is no immediate market impact. Investors should not adjust positions based on this introduction alone. If the bill advances with a clear funding mechanism, potential beneficiaries could include cancer research and biotech firms, but no tickers can be named now.

Full Analysis

The Cancer Research Trust Fund Act (HR10093) was introduced on August 13, 2026, by Rep. Ashley Hinson (R-IA) and referred to the House Committee on Energy and Commerce. The bill is in its earliest legislative stage with no committee hearings or markup scheduled. No funding amount is specified in the available data, and the bill's text is not provided, so the specific mechanism for establishing a trust fund remains unclear. As an authorization-type bill, any funding would require subsequent appropriations, and the lack of cosponsors suggests limited initial momentum. The bill's impact on the healthcare sector is uncertain without text; it could potentially support cancer research funding, but no specific companies or revenue streams can be identified at this stage. The legislative path ahead includes committee consideration, potential amendments, floor votes, and Senate action, all of which are uncertain.

Key Legislators

Rep. Hinson, Ashley [R-IA-2]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Exec OrderAug 6, 2026

Ending Birth Tourism

This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →